Accutest: Delivering Quality Result that Exceeds Expectation

CIO Vendor The global Clinical Research Organization (CRO) is expected to reach $23.6 billion this year. However, India's contribution is a meager 2 percent to this industry despite of it becoming a hub of the CRO industry due to cost effective expertise available to handle various complexities and regulatory challenges.


Delivering Quality Result that Exceeds Expectation


Making a mark in this vital industry in India is Accutest Research Laboratories. This Navi Mumbai based company is a comprehensive drug development company with 62+ accreditations from global regulators like USFDA, WHO, EMA, DCGI, ANVISA, ISP, MCC and many more.

Founded in 1998, Accutest is a leading global CRO based in India, offering end-to-end product development and clinical research under one roof. The company has made an incredible market share of 20 percent in BA/BE space in India through their unmatched expertise and experience to handle simple to most complex molecules while maintaining highest level of quality standards. Their DNA is quality, where nothing is compromised in terms of performance. Meticulous planning in execution and in-depth knowledge allows Accutest to design solutions customized to the client's requirements and deliver quality results with quick turn-around-time exceeding client's expectations.
"As an endorsement to deliver best quality in global CRO segment, we have recently been awarded the 'International Quality Summit Award in the Gold category', and in the field of quality and excellence 'The Majestic Five Continents Award," says a proud Dr. Satish Sawant, Founder & CEO, Accutest Research Laboratories. Lately, the company won India INC.500 award for being one of the fastest growing company.
Living to these recognitions, Accutest has developed a niche for themselves in providing services in the verticals of bioavailability/bioequivalence, formulation development and clinical trials. Their subsidiary, Quantimmune Solutions, helps Accutest offer cutting edge analytical development and testing services for Biologics and Biosimilars which includes protein characterization, bioassays for potency and immunogenicity.
Functional from four sites across India and Mexico, Accutest has CAP & NABL accredited Clinical Laboratories with 376 beds capacity, over 450 bioanalytical methods, a large pool of 44 LC-MS/MS and biologics laboratories with high-end instruments like surface Plasmon resonance, QuantStudio 12K Flex real time PCR etc. State-of-the-art infrastructure is supported with 600+ highly experienced professionals to deliver quality oriented, accurate results within predetermined timelines. This pool of skill gets beaded into an open environment where hierarchy is not a boundary for communication and superior ensures higher level of co-ordination and highly efficient problem solving. This leads to smoother execution of studies and a happy customer. For the coming days, Accutest plans to grow their business through organic expansion, joint ventures and acquisitions while continue to be open for the introduction of latest technology platforms, adoption of new quality concepts and process to cater to the changing needs of the global industry.